Current News Tuesday, February 9, 2010 Biotech Pharma
FDA Postpones Oncologic Drugs Advisory Committee Meeting to Review Pixantrone Due to Severe Weather Conditions
SEATTLE, Feb. 9 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC)... more
Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.
PARIS, Feb. 9 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced... more
New CEO and EUR2.3m Private Placement for Atacama Labs Oy
HELSINKI, February 8 /PRNewswire/ -- As of January 2010 Mr. Steffen
Mittwich has been appointed... more
YM BioSciences reports second quarter 2010 operational and financial results
MISSISSAUGA, ON, Feb. 8 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM),... more
Multi-Cultural
U.S. Census Bureau Black History Month Feature for Feb. 9
WASHINGTON, Feb. 9 /PRNewswire-USNewswire/ -- Following is the daily Black History Month feature... more
'What Does Lunar New Year Mean to You?' Asks Verizon Wireless
WALNUT CREEK, Calif., Feb. 8 /PRNewswire/ -- To kickoff its festivities for the Year of the Tiger... more
Tuesday's Great Gathering Press Conference at the National Press Club Postponed
WASHINGTON, Feb. 8 /PRNewswire/ -- The news conference involving the leadership of the three... more
Power for Living Christ-Centered Lives
PUYALLUP, Wash., Feb. 8 /PRNewswire/ -- God has power that unbelievers know nothing about. God... more
FDA
Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP
SCHAUMBURG, Ill., Feb. 8 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately held specialty... more
Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
HAYWARD, Calif., Feb. 8 /PRNewswire/ -- Anthera Pharmaceuticals, Inc., a privately held... more
Lupin Receives FDA Approval for Amlodipine/Benazepril Capsules
BALTIMORE, Feb. 8 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. announced today that the U.S. Food... more
US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium)
WILMINGTON, Del., Feb. 8 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that... more
|
